Structure-/disease-modifying agents for osteoarthritis

被引：9

作者：

Altman, RD ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA USA

来源：

SEMINARS IN ARTHRITIS AND RHEUMATISM | 2005年 / 34卷 / 06期

关键词：

D O I：

10.1016/j.semarthrit.2004.03.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OA is the most common articular disease. Age is its most notable risk factor. With the aging of the population of the developed world, there will be a growing need for better understanding of OA and for superior therapies. There is increasing appreciation for the role of inflammation in OA. There also is the realization that OA is not only a disease of cartilage, but of the entire joint. This has led to increasing interest in structure/disease modification as the goal in OA therapy. However, there are no universally proven structure-/disease-modifying interventions. © 2005 Elsevier Inc. All rights reserved.

引用

页码：3 / 5

页数：3

共 16 条

[1] A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases [J].

Amin, AR ;

Attur, MG ;

Thakker, GD ;

Patel, PD ;

Vyas, PR ;

Patel, RN ;

Patel, IR ;

Abramson, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14014-14019

[2]

Amin Ashok R., 1998, Arthritis and Rheumatism, V41, pS342

[3]

BRANDT K, 1993, OSTEOARTHR CARTILAGE, V1, P14

[4] TREATMENT OF DEEP CARTILAGE DEFECTS IN THE KNEE WITH AUTOLOGOUS CHONDROCYTE TRANSPLANTATION [J].

BRITTBERG, M ;

LINDAHL, A ;

NILSSON, A ;

OHLSSON, C ;

ISAKSSON, O ;

PETERSON, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :889-895

[5]

COLE AD, 1994, ARTHRITIS RHEUM, V32, P1727

[6] Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro [J].

Doherty, PJ ;

Zhang, HW ;

Tremblay, L ;

Manolopoulos, V ;

Marshall, KW .

OSTEOARTHRITIS AND CARTILAGE, 1998, 6 (03) :153-159

[7] PEER TEACHING IN HIGHER-EDUCATION - REVIEW [J].

GOLDSCHMID, B ;

GOLDSCHMID, ML .

HIGHER EDUCATION, 1976, 5 (01) :9-33

[8]

HUNZIKER EB, 1994, T ORTHOP RES SOC, V19, P236

[9]

Ikeda T, 1998, J RHEUMATOL, V25, P1666

[10] Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo [J].

Lewis, EJ ;

Bishop, J ;

Bottomley, KMK ;

Bradshaw, D ;

Brewster, M ;

Broadhurst, MJ ;

Brown, PA ;

Budd, JM ;

Elliott, L ;

Greenham, AK ;

Johnson, WH ;

Nixon, JS ;

Rose, F ;

Sutton, B ;

Wilson, K .

BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (03) :540-546

← 1 2 →